Odyssey Investment Partners has sold its portfolio company EAG Laboratories to Eurofins Scientific for $780 million. Odyssey acquired EAG Laboratories in September 2008.
EAG Laboratories (previously Evans Analytical Group) is a testing and analysis services company that provides materials surface testing; testing and analysis services to the pesticides, animal health and industrial chemical end markets; and microelectronics test services for semiconductor companies and small to medium-sized integrated device manufacturers.
EAG has more than 4,000 customers that are active in the industrial, aerospace, solar, biomed, pharma, chemical, consumer and technology end markets. The company has 21 laboratories in 18 locations worldwide and serves approximately 4,000 worldwide customers. EAG is headquartered in San Diego (www.eaglabs.com).
Eurofins Scientific (Paris: ERF) is a provider of food, environment and pharmaceutical products testing. The company, with a staff of over 30,000 and 375 laboratories in 41 countries, is headquartered in Luxembourg (www.eurofins.com).
Odyssey makes control investments in middle-market companies in a variety of industries including industrial manufacturing; business, financial and healthcare services; aerospace products; and localized and route-based service businesses. The firm has approximately $3.5 billion of capital under management and has offices in New York and west of Los Angeles in Woodland Hills, CA (www.odysseyinvestment.com).
Harris Williams & Co. (www.harriswilliams.com) was the financial advisor to EAG on this transaction which was led by Brian Lucas, Luke Semple and Ian Thomas of the firm’s Richmond office.
© 2017 Private Equity Professional | December 7, 2017